fbpx
Wednesday, May 27, 2020

Weighing the Risks of Celebrex

Enjoying this article?

You'll love our roundtable.


By submitting this form, you are consenting to receive marketing emails from: Jewish Journal, 3250 Wilshire Boulevard, Los Angeles, CA, 90010, http://www.jewishjournal.com. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Non-steroidal anti-inflammatory medicines (NSAIDs) have been around since the 1960s. They include ibuprofen (Advil, Motrin), naproxen (Aleve), meloxicam (Mobic), diclofenac (Voltaren) and over a dozen others. NSAIDs are used to treat pain, decrease fever, and decrease inflammation. They are prescribed over 100 million times annually in the US. Naproxen and ibuprofen are also available over the counter.

NSAIDs were a boon compared to the medications that were available before them. They are more effective for pain than acetaminophen (Tylenol), and are not addictive like opiates. But they do have some side effects. They decrease platelet function and thereby increase bleeding risk, and they can irritate the stomach lining and even cause ulcers. They can also cause kidney injury. These risks are quite small when used for the occasional headache or muscle sprain, but some patients require long-term daily pain medication. These patients’ risk of stomach bleeding from NSAIDs is substantial.

To address this risk, a novel family of medications emerged in the 1990s – COX-2 inhibitors. These medications were designed to have the analgesic and anti-inflammatory benefits of NSAIDs with much lower gastrointestinal risks. In the US two COX-2 inhibitors became available, celecoxib (Celebrex) in 1998 and rofecoxib (Vioxx) in 1999. But Vioxx was found to increase the risk of stroke and heart attack in patients taking it daily and was withdrawn from the market in 1999.

Thereafter it was discovered that traditional NSAIDs likely also increased stroke and heart attack risk somewhat, but the assumption was that Celebrex increased stroke and heart-attack risk more than NSAIDs because it was in the same family as Vioxx. After Vioxx’s withdrawal, the FDA allowed Celebrex to continue to be sold as long as its effect on stroke and heart attack risk was systematically evaluated. The resulting

The study randomized over 24,000 patients who required daily pain medication for arthritis. (Patients for whom Tylenol was sufficient were excluded.) The patients all had some risk factors for heart disease or stroke. They were randomized to receive celecoxib (Celebrex), ibuprofen, or naproxen. Notably, they were all given esomeprazole (Nexium), a strong acid-blocker, to decrease the risk of developing ulcers. They were treated with these medications for about two years on average and were followed for a few years thereafter. The incidence of stroke, heart attacks, intestinal bleeding, kidney injury and other adverse events were tracked. The patients were also asked about the severity of their arthritis pain.

The results were surprising. The patients receiving Celebrex had strokes and heart attacks at similar rates as the patients receiving ibuprofen or naproxen. There was no evidence of higher stroke or heart attack risk with Celebrex. As expected, the patients taking Celebrex had fewer gastrointestinal side effects than those taking the other medicines. Celebrex was also safer than ibuprofen in terms of kidney injury, but similar to naproxen. The patients achieved very similar levels of pain relief, with the patients receiving naproxen having slightly better relief than those receiving Celebrex or ibuprofen.

Some cardiologists criticized the results, arguing that although the trial was supposed to study patients at high risk for stroke and heart attack, the number of actual heart attacks and strokes observed were quite low, suggesting the study enrolled patients at much lower risk than intended. Still, in the population studied, Celebrex resulted in no more strokes or heart attacks than naproxen or ibuprofen.

The generalizable message is that all pain medications have side effects. For the occasional ache and pain, almost any choice is safe. If prolonged daily pain medication is required, try acetaminophen (Tylenol) first. (Tylenol has important liver and kidney risks that you should discuss with your doctor if you’ll be taking it daily.) If acetaminophen is ineffective, Celebrex (celecoxib) or an NSAID is a reasonable next choice. Celebrex is much less likely to lead to gastrointestinal bleeding. If you take Celebrex or an NSAID daily for weeks or longer, a daily antacid in the proton pump inhibitor (PPI) family is important to protect your stomach. Whichever medication you take, try to find the minimum effective dose and take it for the shortest possible duration.

Learn more:

” target=”_blank”>10-year study eases concerns about Celebrex, heart risk (CNN)
“>Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis (NEJM article)

Enjoyed this article?

You'll love our roundtable.


By submitting this form, you are consenting to receive marketing emails from: Jewish Journal, 3250 Wilshire Boulevard, Los Angeles, CA, 90010, http://www.jewishjournal.com. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Latest Articles

Man Who Held Anti-Semitic Sign at Ohio Protest Wanted to Target Jews at Kent State, Report Says

A man who held an anti-Semitic sign at an April rally in Columbus, Ohio, reportedly sought to target Jews at Kent State University. The Cleveland...

Bench Near Minneapolis Synagogue Vandalized With Swastikas

(JTA) — A bus stop near a synagogue in Minneapolis was vandalized with swastikas. The graffiti was discovered Tuesday on a bench outside Shir Tikvah...

ADL Report Highlights ‘Significant Trend of Anti-Semitism’ in ‘the Anti-Israel Movement on Campus’

The Anti-Defamation League (ADL) released a report on May 27 highlighting how anti-Semitism permeates “the anti-Israel movement on .” The report acknowledged that although the...

A New Relief Fund Is Providing Aid to Jews of Color Who Are Struggling Due to Coronavirus

(JTA) — A new relief fund is providing financial aid to Jews of color who are struggling economically due to the coronavirus pandemic. The Jews...

Pandemic Times Episode 47: The Value of Storytelling

New David Suissa Podcast Every Morning at 11 a.m. A conversation on the unique power of storytelling with Rutger Bruining in London, founder of Story...

Obituaries: May 29, 2020

Beth Abramowitz died May 12 at 54. Survived by mother Barbara; father Abraham; brother David. Hillside  Louis Bauman died May 7 at 84. Survived by wife Myrna;...

Letters: Jewish Virtual Weddings, Masa Israel’s Legacy 

Prager’s Lockdown Story Dennis Prager’s “The Worldwide Lockdown May Be the Greatest Mistake in History” (May 8) validly complains that the left too often dismisses...

American Jews, This Shavuot it’s Time We Rededicate Ourselves to Social Justice

In April, we celebrated Passover during a modern-day plague. Over the past two months, the world has seen the horrors of that plague unfold....

Holidays and the Environment: From Shavuot to Dairy to Desalination

To prevent public gatherings during COVID-19, Lag BaOmer took place without bonfires, resulting in a significant reduction in air pollution. Now, Shavuot will be...

Israeli Defense Ministry: Gaucher’s Disease Drugs Can Treat COVID-19

The Israeli Defense Ministry announced on May 26 that the Israeli Institute for Biological Research (IIBR) has determined that two drugs used for Gaucher’s...

Culture


‘Love & Stuff’ Sees Life, Death and Motherhood Through a Jewish Lens

How do you cope with both the death of a parent and the artifacts she left behind, while preparing to become a mother yourself...

Jews of Color Campaign Goes Viral After Article Relegates Them to a Statistic

Numbers have always held significance in Jewish culture, but without purpose, they can be harmful. This was borne out in a May 17 eJewish...

A Savory Shavuot Feast With a Sweet Finale

It was a sacred tradition. We would load up our minivans with lots and lots of food and our kids and head to the...

Why Summer Camp Is So Important to American Jews

Every summer, tens of thousands of American Jewish kids leave their homes, board buses and planes, and spend a month or two together on...

Diane Warren’s ‘I’m Standing with You’ Music Video to Raise Funds for COVID-19 Response

“I’m Standing with You,” songwriter Diane Warren’s Oscar-nominated theme from the movie “Breakthrough,” has gone global in a new video in support of the...

Latest Articles
Latest

Man Who Held Anti-Semitic Sign at Ohio Protest Wanted to Target Jews at Kent State, Report Says

A man who held an anti-Semitic sign at an April rally in Columbus, Ohio, reportedly sought to target Jews at Kent State University. The Cleveland...

Bench Near Minneapolis Synagogue Vandalized With Swastikas

(JTA) — A bus stop near a synagogue in Minneapolis was vandalized with swastikas. The graffiti was discovered Tuesday on a bench outside Shir Tikvah...

ADL Report Highlights ‘Significant Trend of Anti-Semitism’ in ‘the Anti-Israel Movement on Campus’

The Anti-Defamation League (ADL) released a report on May 27 highlighting how anti-Semitism permeates “the anti-Israel movement on .” The report acknowledged that although the...

A New Relief Fund Is Providing Aid to Jews of Color Who Are Struggling Due to Coronavirus

(JTA) — A new relief fund is providing financial aid to Jews of color who are struggling economically due to the coronavirus pandemic. The Jews...

Pandemic Times Episode 47: The Value of Storytelling

New David Suissa Podcast Every Morning at 11 a.m. A conversation on the unique power of storytelling with Rutger Bruining in London, founder of Story...

Hollywood


‘Love & Stuff’ Sees Life, Death and Motherhood Through a Jewish Lens

How do you cope with both the death of a parent and the artifacts she left behind, while preparing to become a mother yourself...

‘Arrowverse’ Showrunner Greg Berlanti on Whether He’s Jewish or Not

Greg Berlanti is the executive producer of “Arrow,” “Supergirl,” “Titans,” “Riverdale” and “The Flash.” Between keeping his die-hard DC fans satisfied, the mega-producer also...

Jewish Grandpa Seeks Out The Family Who Hid Him From Nazis in Documentary “The Starfish”

New York director and producer, Tyler Gildin, through his media company Gildin Media, released a documentary titled The Starfish, exploring the life story of his grandfather,...

Podcasts

Pandemic Times Episode 47: The Value of Storytelling

New David Suissa Podcast Every Morning at 11 a.m. A conversation on the unique power of storytelling with Rutger Bruining in London, founder of Story...

Matti Friedman: Israel’s forgotten war

Shmuel Rosner and Matti Friedman discuss Matti's new book, "Pumpkinflowers: A Soldier's Story of a Forgotten War," Israel's war in Lebanon and why it...

More news and opinions than at a Shabbat dinner, right in your inbox.


By submitting this form, you are consenting to receive marketing emails from: Jewish Journal, 3250 Wilshire Boulevard, Los Angeles, CA, 90010, http://www.jewishjournal.com. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

x